Small Intestinal Bacterial and Fungal Overgrowth: Health Implications and Management Perspectives

Area of Science:

• Gastroenterology
• Microbiology
• Internal Medicine

Background:

• Small Intestinal Bacterial Overgrowth (SIBO) and Small Intestinal Fungal Overgrowth (SIFO) involve increased microbial populations in the small intestine.
• SIBO stems from bacterial overgrowth, while SIFO is driven by fungi, often *Candida* species.
• Both conditions present with non-specific gastrointestinal symptoms like bloating, pain, diarrhea, and malabsorption, complicating diagnosis.

Purpose of the Study:

• To review the mechanisms, risk factors, diagnostic challenges, and management strategies for SIBO and SIFO.
• To differentiate between SIBO and SIFO, highlighting their distinct yet overlapping characteristics.
• To emphasize the need for improved diagnostic tools and a multidisciplinary approach for optimal patient care.

Main Methods:

• A comprehensive literature review was performed.
• Focus was placed on pathophysiology, diagnostic modalities, and therapeutic approaches for SIBO and SIFO.

Main Results:

• SIBO is linked to reduced gastric acid, impaired motility, and structural abnormalities; diagnosed via jejunal aspirates or breath tests.
• SIFO is associated with antibiotic use, immunosuppression, and dysbiosis; diagnosed via small intestinal fungal cultures.
• Standardized diagnostic protocols for SIFO are currently lacking.

Conclusions:

• Clinical overlap and misdiagnosis of SIBO and SIFO necessitate better diagnostic tools.
• Understanding the mechanisms and interrelation of SIBO and SIFO is crucial for effective management.
• A multidisciplinary approach is recommended to optimize patient outcomes for these conditions.